首页> 外国专利> LKKTET AND/OR LKKTNT PEPTIDE COMPOSITIONS WHICH ARE LYOPHILIZED OR IN A FORM CAPABLE OF BEING LYOPHILIZED

LKKTET AND/OR LKKTNT PEPTIDE COMPOSITIONS WHICH ARE LYOPHILIZED OR IN A FORM CAPABLE OF BEING LYOPHILIZED

机译:LKKTET和/或LKKTNT肽组合物已被液化或呈能够被液化的形式

摘要

An ophthalmically acceptable composition for use in the treatment of a corneal epithelial wound in a subject that has undergone or is undergoing a surgical procedure or corneal resurfacing procedure, the composition comprising a peptide agent comprising amino acid sequence LKKTET (SEQ ID NO: 1) or Thymosin β4 (Tβ4) in an aqueous composition at a concentration of about 1 mg/ml to 6mg/ml having a pH of about 5.5 to 7.8.
机译:一种眼科上可接受的组合物,用于治疗已经或正在进行外科手术或角膜表面置换手术的受试者的角膜上皮伤口,该组合物包含肽试剂,该肽试剂包含氨基酸序列LKKTET(SEQ ID NO:1)或水性组合物中的胸腺素β4(Tβ4)的浓度为约1mg / ml至6mg / ml,pH为约5.5至7.8。

著录项

  • 公开/公告号EP3326647A1

    专利类型

  • 公开/公告日2018-05-30

    原文格式PDF

  • 申请/专利权人 REGENERX BIOPHARMACEUTICALS INC.;

    申请/专利号EP20170204441

  • 发明设计人 GOLDSTEIN ALLAN L.;CROCKFORD DAVID;

    申请日2006-06-19

  • 分类号A61K39/38;A61K38/02;A61P27/02;

  • 国家 EP

  • 入库时间 2022-08-21 13:15:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号